Evidence map›Paper›PMID 35495027›Full record

ArticleFrontiers in neuroscience2022

Plasma Neurofilament Light Chain Levels Are Elevated in Children and Young Adults With Wolfram Syndrome.

Sarah A Eisenstein, Raveena S Boodram, Courtney L Sutphen, Heather M Lugar, Brian A Gordon, Bess A Marshall, Fumihiko Urano, Anne M Fagan, Tamara Hershey

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sarah A EisensteinDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
Raveena S BoodramDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
Courtney L SutphenDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
Heather M LugarDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
Brian A GordonMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.
Bess A MarshallDepartment of Pediatrics, Washington University School of Medicine, St. Louis, MO, United States.
Fumihiko UranoDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, United States.
Anne M FaganDepartment of Neurology, Washington University School of Medicine, St. Louis, MO, United States.
Tamara HersheyDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.
Washington University in St. Louis · USMallinckrodt (United States) · USHope Center for Neurological Disorders · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Washington University Intellectual and Developmental Disabilities Research Center-Administrative Down Syndrome SupplementU54HD087011 · NICHD · WASHINGTON UNIVERSITY · PI WOZNIAK, DAVID FRANCIS · 2015 to 2019
$7.1M
TRACKING NEURODEGENERATION IN EARLY WOLFRAM SYNDROMER01HD070855 · NICHD · WASHINGTON UNIVERSITY · PI HERSHEY, TAMARA G · 2012 to 2022
$5.6M
Translational Training in Aging and Alzheimer’s Disease Related DisordersT32AG033534 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI STEPHEN B. KRITCHEVSKY · 2009 to 2026
$3.6M
ENDOPLASMIC RETICULUM IN BETA CELLSR01DK112921 · NIDDK · WASHINGTON UNIVERSITY · PI URANO, FUMIHIKO · 2017 to 2019
$1.1M
Neuroimaging Markers of Emerging Dysfunction In Preclinical Alzheimer DiseaseK01AG053474 · NIA · WASHINGTON UNIVERSITY · PI GORDON, BRIAN ANDREW · 2017 to 2021
$623k
CLINICAL TRIAL OF DANTROLENE SODIUM IN PATIENTS WITH WOLFRAM SYNDROMER21DK113487 · NIDDK · WASHINGTON UNIVERSITY · PI URANO, FUMIHIKO · 2017 to 2018
$419k
AN ENDOPLASMIC RETICULUM CALCIUM STABILIZER FOR THE TREATMENT OF WOLFRAM SYNDROMEUH3TR002065 · NCATS · WASHINGTON UNIVERSITY · PI URANO, FUMIHIKO · 2019 to 2019
$153k
NCATS NIH HHS UH3 TR002065NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NCRR NIH HHS UL1 RR024992NIA NIH HHS K01 AG053474NIA NIH HHS T32 AG033534NICHD NIH HHS R01 HD070855NICHD NIH HHS U54 HD087011NIDDK NIH HHS P30 DK020579NIDDK NIH HHS R01 DK112921NIDDK NIH HHS R21 DK113487
6 · The paper itself

Abstract

Wolfram syndrome is a rare disease caused by pathogenic variants in the

Indexed as

axonal injuryneurodegenerationneurofilament light chainthalamusWFS1 geneWolfram syndrome

Identifiers

PMID35495027
PMCPMC9039397
OpenAlexW4223584403

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.